Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: CTKB

Cytek Biosciences, Inc.

Healthcare | Medical - Devices

No licensed closing price on file for CTKB. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

Cytek Biosciences, Inc. (NASDAQ: CTKB) is a medical device company. Figures from SEC EDGAR; updated 2026-10-21 11:45 UTC.

What Cytek Biosciences, Inc. does

The company is a cell analysis solutions provider that develops instruments and software for analyzing individual cells in biological research and clinical settings. Its patented Full Spectrum Profiling technology collects light emissions across multiple wavelengths to identify up to 50 different fluorescent markers on cells simultaneously, addressing limitations of conventional flow cytometry and competing technologies. The company offers cell analyzer systems, a cell sorter system, and complementary software and reagents for a comprehensive platform.

Summarized from Cytek Biosciences, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
Return on equity-19.47%

Revenue, margins & earnings

FY2021 Net income: $3MFY2021 Taxes & interest: $6MFY2021 Operating expenses: $70MFY2021 Cost of revenue: $49M$128MFY2021FY2022 Revenue: $164M — margin split not shown (non-operating gains)$164MFY2022FY2023: net loss $12M on revenue $193M$193MFY2023FY2024: net loss $6M on revenue $200M$200MFY2024FY2025: net loss $67M on revenue $201M$201MFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-08-20
  • 2026-08-20Chief Financial OfficerOption exercise16,049—
  • 2026-08-20Chief Financial OfficerRestricted Stock UnitsOption exercise-13,051—
  • 2026-08-20Chief Financial OfficerRestricted Stock UnitsOption exercise-6,320—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Cytek Biosciences, Inc. do?

The company is a cell analysis solutions provider that develops instruments and software for analyzing individual cells in biological research and clinical settings.

When did CTKB last file with the SEC?

Cytek Biosciences, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-25. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-21 11:45 UTC. This page is also available as JSON at /api/data?ticker=CTKB and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for CTKB and 5,000+ tickers.

Create a free account — keep CTKB
For your agent
GET /api/data?ticker=CTKB

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt